Live from ESMO 2024 | Ascentage Pharma Releases Latest Data Showing Sustained Clinical Efficacy of Olverembatinib in SDH-Deficient GIST during a Mini Oral Presentation September 14, 2024 β 08:18
Transcenta Holding Limited (Stock Code: 6628.HK) Announce 2024 Interim Results August 29, 2024 β 14:31
2024 World Life Science Conference Scheduled for October 19 in Hainan, China August 18, 2024 β 20:20
ACROBiosystems Launches GMP Brand Resilient Supply at ISSCR to Accelerate Cell and Gene Therapy Development July 19, 2024 β 00:00